Krensavage Asset Management, LLC Bio N Tech Se Transaction History
Krensavage Asset Management, LLC
- $178 Million
- Q3 2024
A detailed history of Krensavage Asset Management, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Krensavage Asset Management, LLC holds 93,583 shares of BNTX stock, worth $10.9 Million. This represents 6.23% of its overall portfolio holdings.
Number of Shares
93,583
Previous 132,293
29.26%
Holding current value
$10.9 Million
Previous $10.6 Million
4.55%
% of portfolio
6.23%
Previous 4.88%
Shares
3 transactions
Others Institutions Holding BNTX
# of Institutions
357Shares Held
38.3MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$971 Million0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$528 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$509 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$221 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$211 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28.4B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...